Cancer patients need better care, not just more technology

Nature. 2017 Sep 19;549(7672):325-328. doi: 10.1038/549325a.

Authors

Richard Sullivan¹, C S Pramesh², Christopher M Booth³

Affiliations

¹ King's College London, and director of the King's Institute of Cancer Policy, London, UK.
² Tata Memorial Centre, Mumbai, India, and convener of the National Cancer Grid of India.
³ population cancer care at Queen's University Cancer Research Institute, Kingston, Canada.

PMID: 28933447
DOI: 10.1038/549325a

No abstract available

MeSH terms

Africa South of the Sahara / epidemiology
Bevacizumab / economics
Bevacizumab / therapeutic use
Biomedical Technology* / economics
Biomedical Technology* / trends
Early Detection of Cancer / economics
Europe / epidemiology
Female
Global Health / economics
Global Health / standards
Health Services Needs and Demand* / economics
Humans
Male
Neoplasms / drug therapy*
Neoplasms / mortality*
Neoplasms / radiotherapy
Neoplasms / surgery
Pathology / education
Public Health / economics
Public Health / standards
Quality of Life
Survival Rate
Tamoxifen / economics
Tamoxifen / therapeutic use
Workforce

Substances

Tamoxifen
Bevacizumab